Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Uterine Neoplasms × Aprepitant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 8 Nausea 4 Lymphoma 3 Breast Neoplasms 3 Neoplasms 2 Leukemia 2 Uterine Neoplasms 1 Thyroid Neoplasms 1 Sezary Syndrome 1 Pruritus 1 Post-Dural Puncture Headache 1 Ovarian Neoplasms 1 Hematologic Neoplasms 1

Interventions

Saline Solution 2 fosaprepitant 1 fluciclovine F-18 1 ferrous fumarate 1 Lidocaine 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Gynecologic Oncology Associates

Phase 4 Completed

20 enrolled 5 charts

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡